The Alliance for Cellular Signaling Plasmid Collection: A Flexible Resource for Protein Localization Studies and Signaling Pathway Analysis by Zavzavadjian, Joelle R. et al.
The Alliance for Cellular Signaling Plasmid
Collection
A FLEXIBLE RESOURCE FOR PROTEIN LOCALIZATION STUDIES AND SIGNALING PATHWAY ANALYSIS*□S
Joelle R. Zavzavadjian‡§, Sam Couture‡§, Wei Sun Park‡¶, James Whalen‡¶,
Stephen Lyon‡, Genie Lee‡§, Eileen Fung‡§, Qingli Mi‡§, Jamie Liu‡§, Estelle Wall‡§,
Leah Santat‡§, Kavitha Dhandapani‡§, Christine Kivork‡§, Adrienne Driver‡§,
Xiaocui Zhu‡§, Mi Sook Chang‡§, Baljinder Randhawa‡§, Elizabeth Gehrig‡¶,
Heather Bryan‡¶, Mary Verghese‡¶, Andreia Maer‡, Brian Saunders‡, Yuhong Ning‡,
Shankar Subramaniam‡, Tobias Meyer‡¶, Melvin I. Simon‡§, Nancy O’Rourke‡¶,
Grischa Chandy‡¶, and Iain D. C. Fraser‡§**
Cellular responses to inputs that vary both temporally and
spatially are determined by complex relationships be-
tween the components of cell signaling networks. Analy-
sis of these relationships requires access to a wide range
of experimental reagents and techniques, including the
ability to express the protein components of the model
cells in a variety of contexts. As part of the Alliance for
Cellular Signaling, we developed a robust method for
cloning large numbers of signaling ORFs into Gateway
entry vectors, and we created a wide range of compatible
expression platforms for proteomics applications. To
date, we have generated over 3000 plasmids that are
available to the scientific community via the American
Type Culture Collection. We have established a website at
www.signaling-gateway.org/data/plasmid/ that allows
users to browse, search, and blast Alliance for Cellular
Signaling plasmids. The collection primarily contains mu-
rine signaling ORFs with an emphasis on kinases and G
protein signaling genes. Here we describe the cloning,
databasing, and application of this proteomics resource
for large scale subcellular localization screens in mam-
malian cell lines. Molecular & Cellular Proteomics 6:
413–424, 2007.
Analysis of cross-talk between signaling pathways when
mammalian cells are challenged with multiple ligand stimuli
and the development of molecular models that describe sig-
nal integration and processing provide key insight to cellular
signaling mechanisms and the regulation of cellular function
(1, 2). Two strategic requirements in projects of this nature are
the identification of the protein components in a given model
system (the so-called “parts list”) and the ability to modulate
the expression and function of these protein components. At
the outset of the Alliance for Cellular Signaling (AfCS)1 project
(1), reagent availability was a central issue, and in the case of
cDNA clones, there was no publicly accessible repository of
validated mouse sequences. Moreover the nature of the pro-
ject demanded the establishment of standardized methodol-
ogy for the isolation of cDNAs and their expression in a variety
of contexts. The emergence of recombination-based cloning
technologies was timely and allowed the development of a
robust cloning platform. We adopted Invitrogen’s Gateway
system that allows facile transfer of DNA segments into mul-
tiple expression platforms while maintaining orientation and
reading frame register (3–5).
Several reports have described efforts to generate genome-
wide collections of cDNAs (6, 7) and the production of “OR-
Feome” sets of sequence-validated open reading frames (8–
10). The generation of “ORF-only” clones in these latter efforts
is key for downstream proteomics applications that require
expression of proteins with N- or C-terminal fusion tags (11–
14). The AfCS cloning effort has focused on genes involved in
cell signaling and therefore does not approach the scale of
these genome-wide projects. However, as the described OR-
Feome cloning projects have concentrated on model orga-
nisms other than mouse, the AfCS-generated plasmids re-
main, to our knowledge, the largest collection of mouse ORF-
only clones available through a non-commercial source.
Using a set of mouse serine-threonine kinase (STK) genes
as an example, we describe the development of protocols and
vectors contained in the AfCS plasmid database. This repos-
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itory has grown into a significant resource of several thousand
plasmids that have been made available to the scientific com-
munity through the ATCC. Certain gene families with key roles
in cell signaling such as kinases and heterotrimeric G proteins
are highly represented in the database. We have created
expression vectors permitting facile recombination-based
generation of fluorescent protein fusions for imaging applica-
tions and affinity tag fusions for immunoprecipitation of pro-
tein complexes. Using the former expression platform, we
have carried out large scale subcellular localization studies in
murine cell lines to create the AfCS image database. We
present selected subcellular localization data to demonstrate
the functional utility of this resource.
EXPERIMENTAL PROCEDURES
Detailed protocols developed by the AfCS are available on line at
www.signaling-gateway.org/data/ProtocolLinks.html. Brief summa-
ries of key procedures are described below.
Design of Scripts
Cloning Primers—Cloning primers of a defined minimum length,
starting at the termini of each ORF and with a melting point above a
minimum desired temperature (Tm  70 °C), were designed using an
in-house Perl script. The calculations in the script were performed as
described previously (15, 16) based on 50 mM salt and 50 nM DNA
concentrations. The attB Gateway recombination sites were added to
the primer sequence after the Tm calculations (Fig. 1 and Supplemen-
tal Table 1).
Sequence Primers—We utilized Primer3 (17) to generate sequenc-
ing primers at approximately equal intervals along a sequence (Fig. 3b
and Supplemental Table 2). Assuming we need n pairs of primers
based on clone length L and interval length l (e.g. 500 bp), we then ran
Primer3 n  1 times. Generally we targeted the interval between the
coordinates we wanted for the mth primer on the positive strand
(minus a window, e.g. 50 bp) and for the (n  m)th primer on the
negative strand (plus a window, e.g. 50 bp). The coordinates refer to
the positive strand position (i.e. position y on the reverse strand is
actually L  y on the forward strand). For the first reverse primer, we
defined one excluded area up to the end of the clone and ran Primer3
to design a pair of primers. We then took only the reverse primer.
Primer3 accepts different values for product size, primer GC content,
primer size, and primer melting point. For each m  1 (up to the last
one), we used those coordinates to define two excluded zones (from
those coordinates to the closest clone ends) and generated a pair of
primers using the product size parameter. For the last forward primer,
we proceeded similarly to the first reverse primer, with one excluded
zone, but only kept the forward primer.
RNA Source and cDNA Preparation
1 g of mouse brain, testis, or spleen poly(A) RNA (Clontech) was
used for first strand synthesis using the cDNA Synthesis System
(Invitrogen), subaliquoted, and stored at 20 °C.
Amplification of attB PCR Products for Target Genes
Primers were purchased resuspended to 100 M (Invitrogen). 38 ng
of brain cDNA and 38 ng of testis cDNA were combined for amplifi-
cation of target genes with ProofStart DNA polymerase (Qiagen)
including Q-solution in a total reaction volume of 50 l. Products were
amplified using the following cycling program: 95 °C for 5 min, 94 °C
for 30 s, 72 °C for 6 min (five cycles), 94 °C for 30 s, 70 °C for 6 min
(five cycles), 94 °C for 30 s, 68 °C for 6 min (25 cycles), 4 °C hold.
Amplification products were visualized on a 1% agarose, ethidium
bromide gel. The correct bands were excised and purified using the
QIAquick Gel Extraction kit (Qiagen) and eluted in 30 l EB buffer
(Qiagen).
BP Reactions and Entry Clone Diagnostics
150 ng of pDONR207 was combined with 50–150 ng of purified
attB PCR product, 2 l of BP Clonase enzyme, and 2 l of BP
Reaction Buffer (Invitrogen), and the volume was adjusted to 10
l/reaction using Milli-Q purified water. After incubation at room
temperature for 1 h, 1 l of Proteinase K was added, and reactions
were incubated at 37 °C for 10 min. 5 l of the reaction mixture was
used to transform TOP10 cells (Invitrogen), and recombinants were
selected on gentamicin plates (10 g/ml). Entry clone candidates
were identified by digestion with the BanII restriction enzyme (New
England Biolabs).
Sequence Reactions, Assembly, and Analysis
Sequence reactions were submitted to Macrogen Inc. (Seoul,
South Korea) or Elim Biopharmaceuticals, Inc. (Hayward, CA) in 96-
well plate format. 5 l of miniprep DNA and 5 l of sequencing primer
at 2 M (Invitrogen) were dispensed per well in separate plates.
Sequencing output traces were input into Paracel Genome Assembler
(PGA) to generate one contig per sequenced ORF. Contigs were
imported into OMIGA 2.0 (Oxford Molecular) for alignment against
target ORFs and for further analysis.
LR Reactions and Expression Clone Diagnostics
100 ng of pEN was combined with 100 ng of pDS, 2 l of LR
Clonase enzyme, and 2 l of LR Reaction Buffer (Invitrogen), and the
volume was adjusted to 10 l/reaction using Milli-Q purified water.
After reactions were incubated at room temperature for 1 h, 1 l of
Proteinase K was added, and reactions were incubated at 37 °C for
10 min. 5 l of the reaction mixture was transformed in TOP10 cells
(Invitrogen), and recombinants were selected on kanamycin (10 g/
ml) or ampicillin (50 g/ml) plates. Expression clone candidates were
validated by restriction digest usually with the NcoI restriction enzyme
(New England Biolabs).
Plasmid Database
The AfCS plasmid database structure is broadly composed of three
parts. The first part is the vector information that consists of the
“parent_vector,” “target_gene,” “cloned_gene,” “construct,” and
“misc_plasmid” tables used for storing sequences, features, and
related information about vectors. Plasmid map diagrams are gener-
ated from this information using CGView (18) and cached in the
corresponding “map” tables. For AfCS users, certain functions have
been implemented for generating collections of records, e.g. a parent
vector may be selected followed by a search for cloned genes to
create a set of construct records in batch format. In this case, the
construct sequences are generated from the parent vector template
and the cloned gene sequence, whereas the construct feature offsets
are adjusted from the parent vector template features. The second
part is laboratory storage information that uses the “plasmid_prep”
and “prep_storage_list” tables to track samples that have been cre-
ated in the laboratory in terms of their location (freezer, box, and
position). The third part is the batch system that allows collections of
parent_vector, cloned_gene, construct, and plasmid_prep records to
be grouped together. Various functions have been created to operate
on batches to simplify routine processing for AfCS laboratory person-
nel. For example, storage location records may be generated for
samples by automatically or manually assigning the next sequentially
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available box and position; barcode files for label printing may be
generated from the batch records; data files may be created for
exporting construct information to ATCC. This flexible approach al-
lows additional batch-oriented functions to be easily added to the
programs.
Subcellular Localization in RAW264.7 Cells
A short summary of the steps taken is presented along with the
AfCS protocol identification number referenced in parentheses. RAW
264.7 cells were grown in Dulbecco’s modified Eagle’s medium sup-
plemented with 10% heat inactivated fetal bovine serum at 37 °C with
5% CO2 (PP00000159). Cells were transiently transfected with 0.5 g
of each DNA and 1 l of Lipofectamine 2000 (Invitrogen). The protocol
was modified from the manufacturer’s usual method so that the cells
were simultaneously transfected and plated onto an 8-well coverglass
chamber (PP00000182). Live cell confocal images were collected
20–30 h after transfection. Images were collected on an automated
Zeiss Axiovert with 100 oil objective using a Nipkow spinning disk.
The automated (PP00000143) microscope and camera (Photometrics
CoolSnap HQ) were controlled using MetaMorph software (Molecular
Devices Corp.).
RESULTS
Primer Design and Amplification of attB PCR Products—To
develop a methodological platform for efficient cloning of
large numbers of signaling ORFs for the AfCS research effort,
we chose the STK gene family (19, 20) as a pilot project as it
was well represented in the public sequence databases at the
outset of the AfCS program. We queried the simple modular
architecture research tool (SMART) database (21, 22) to gen-
erate a comprehensive, yet unique, list of ORFs and identified
217 distinct murine STK ORFs based on the information pub-
licly available in 2001. As different applications might require
the ability to express either N- or C-terminal fusions of the
cloned cDNAs, we generated two forms of each ORF: T and
N. The former includes the stop codon allowing for N-terminal
tagging, whereas the latter lacks this codon to permit C-
terminal fusions. To allow facile subcloning of cDNAs to mul-
tiple expression platforms, we used the Gateway recombina-
tion-based cloning technology (4).
It has been demonstrated that PCR isolation of cDNAs from
complex mixtures can be facilitated by amplification protocols
that use combined annealing/extension steps that decrease
stepwise from high temperatures (so-called “touchdown
PCR” (23)). Because these protocols require high initial primer
annealing temperatures, we designed a Perl script (see “Ex-
perimental Procedures”) that processes input ORF sequences
(in FASTA format) to generate cloning primers with a Tm of
70 °C (Supplemental Table 1). The schematic in Fig. 1 shows
the design and nomenclature of the cloning primers for am-
plification of the T and N forms of each ORF. We initially
tested several mRNA sources and found a mixture of mouse
brain and testes to be optimal for amplification of most sig-
naling target mRNAs, whereas hematopoietic-specific target
mRNAs were more often isolated from a mouse spleen source
(data not shown). We used the hot start-activated ProofStart
DNA polymerase enzyme for amplification as its proprietary
chemical modification ensures that primers remain intact dur-
ing setup to prevent mispriming, and it offers efficient exonu-
clease activity for high fidelity (10 times greater than Taq DNA
polymerase). Fig. 2 shows a typical example of attB PCR
amplification of a subset of our targeted STKs from brain/
testes cDNA. Of the 434 PCRs attempted for the initial STK
target set (T and N forms of 217 ORFs), we amplified 375
products based on expected size (data not shown).
Recombinational Cloning and Sequence Analysis—Purified
PCR products were recombined with pDONR207 in a BP
reaction to generate entry vectors for each target mRNA (4).
pDONR207 was favored over other commercially available
donor vectors as it produces gentamicin-resistant entry
clones compatible for recombination to either ampicillin- or
kanamycin-based expression vectors.
In moderate to high throughput cloning protocols, it is
helpful to have a simple diagnostic method to reliably identify
clone candidates prior to sequencing. The redundancy in the
BanII recognition site (GPuGCPyC where Pu is purine and Py
is pyrimidine) leads to a higher likelihood of internal restriction
sites being present in most target genes, increasing variation
in expected banding patterns from ORFs of similar length and
allowing for more reliable identification of correct clones. Fur-
thermore the entry vector backbone derived from pDONR207
contains only two BanII sites that conveniently flank the ORF.
Thus, the parent vector backbone contributes a single 3-kb
band in screens for pEN candidates thereby minimizing inter-
ference when analyzing sizes of gene-specific bands. We
FIG. 1. Design of attB gene-specific PCR amplification primers. Forward primer (I5) contains attB1 sequence, and reverse primers (T3 and
NT3) contain attB2 sequence. I5 and T3 primer pair amplifies the T form of target gene, whereas I5 and NT3 primer pair amplifies the N form.
Note that the bracketed sequence complementary to the stop codon is included in the T3 primer but is omitted from NT3 primer. All primers
extend to a Tm of 70 °C exclusive of the attB sequence.
The AfCS Plasmid and Imaging Databases
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developed a simple Perl script to output expected BanII di-
gest patterns for any number of ORFs input in FASTA format.
An example of a diagnostic digest of 16 entry clones is shown
in Fig. 3a. Using this screening method, we identified se-
quence candidates for 95% of the STK ORFs that went
through BP recombination in our initial clone set.
The Primer3 PCR primer program (17) was customized to
autogenerate sequence primers along both DNA strands of
each target ORF spaced 500 bases apart (see “Experimen-
tal Procedures” and Supplemental Table 2). Two entry vector-
specific flanking primers were also used for each ORF to
provide extensive coverage of both strands of each se-
quenced clone (Fig. 3b). We used PGA software to assemble
the output from each set of sequencing reactions into a single
contig. PGA utilizes an algorithm that allows comparison of
base calls in the raw sequencing data to evaluate and select
the most accurate reading. We found that the combination of
generous overlap between individual contigs from the 500-
nucleotide spacing of primers and the efficient analysis of the
PGA software provided a robust protocol for generation of
high quality sequence data. More importantly, the generation
of N and T forms for each ORF, from separate amplification
reactions, allowed us to better differentiate between PCR-
generated mutations and genuine variants due to splice dif-
ferences or polymorphisms. We found many cases where our
amplified sequence did not precisely match the reference
sequence in GenBankTM. This disagreement could be caused
by randomly generated PCR-based mutations. However, if
the same “mutation” occurred in the independently amplified
T and N forms of a given gene, the chance that this difference
was introduced randomly by amplification was considered
negligible, and the clones in question were databased as
valid. Details of any such differences between our target and
cloned cDNAs (target ORF versus AfCS ORF) were recorded
in the AfCS plasmid database (described below).
Design, Structure, and Content of the AfCS Plasmid Data-
base—One advantage of the Gateway cloning platform is that
it consists of standard backbones for each parent vector into
which cDNAs are incorporated at invariant recombination
sites. In this context, the union of a “parent” vector backbone
and a sequence-validated “cloned gene” generates a con-
struct. With regard to standard Gateway nomenclature in this
system, both entry vectors (pEN) and expression vectors
(pEX) containing a cloned cDNA are constructs, whereas des-
tination vectors (pDS) are parents (Fig. 4). We designed the
AfCS plasmid database to build and curate these various
vector types. This database combines cloned gene and par-
ent vector template information, and it uses custom Perl
scripts to automatically generate detailed construct records
and maps (Supplemental Fig. 1, a and b). To facilitate tracking
of these vectors, we created a barcode system for ready
identification of relevant components and properties (Fig. 4).
This database structure supports the generation of detailed
records for the large number of constructs generated by the
AfCS consortium. The details for a given cloned cDNA only
require one initial entry to the database; all subsequent con-
struct records created using that sequence are autogener-
ated. We found this particularly valuable for 96-well-based
applications where a plate of 96 entry clones could be sub-
cloned by LR recombination to a set of four CFP and YFP
FIG. 2. attB PCR amplification of target cDNAs. An example of attempted attB PCR of 25 murine kinases ranging in size from 0.9 to 3.6
kb is shown. Each reaction is loaded over two lanes except lane 13. 20 of the 25 reactions (80%) produce an amplification product of the
expected ORF size.
The AfCS Plasmid and Imaging Databases
416 Molecular & Cellular Proteomics 6.3
 at California Institute of Technology on July 30, 2007 
w
w
w
.m
cponline.org
D
ow
nloaded from
 
fusion expression vectors for microscopy studies (Fig. 5). The
database was designed to permit effortless combination of
the 96 “cloned cDNAs” with each of the four parent vector
sequence “templates” to create 384 construct records con-
taining full sequence and recommended diagnostic digests to
validate recombinants. The plasmid database software is a
standard web-based database application that consists of a
collection of Perl common gateway interface (CGI) programs
for display and data entry and uses an Oracle database for
persistence (Supplemental Fig. 2 and “Experimental
Procedures”).
The publicly accessible version of the database contains
constructs that have been made available to the research
community through the ATCC (see their molecular genomics
clone search on line). Users can view, browse, and search the
list of available vectors at www.signaling-gateway.org/data/
plasmid/ where barcodes link to the detailed construct
records including full sequence and plasmid maps (Supple-
mental Fig. 1, a and b). The database also contains details on
a number of available AfCS-developed parent vectors that
can be used to create expression constructs for a range of
applications from tagging of cDNAs with GFP derivatives to
affinity tags for proteomics applications (Supplemental Table
3). Although the majority of AfCS “expression-ready” con-
structs available from the ATCC are CFP or YFP fusions (1898
of a total 3076 constructs containing cDNA), we have also
deposited all of the cloned ORFs as entry vectors (1178 of the
3076) that can be used to move the ORFs to any of the parent
vectors described in Supplemental Table 3 or to any other
Gateway-ready vector.
Subcellular Localization of cDNAs in RAW264.7—As de-
scribed above, a large proportion of the vectors generated for
AfCS studies were CFP and YFP fusion constructs for micros-
copy studies. In an effort to generate a database describing
the subcellular localization of signaling genes in AfCS model
cell types, we utilized multiple constructs for each cloned
gene. We carried out a large scale assessment of subcellular
localization of the STKs in both the RAW264.7 murine mac-
rophage cell line and the WEHI231 murine B cell line. This
data set is part of the freely available image database found
on the AfCS data center (www.signaling-gateway.org/data/
Data.html). In this analysis, we co-expressed the same protein
N- or C-terminally fused with C/YFP in the following fashion:
protein-CFP  YFP-protein and CFP-protein  protein-YFP.
We visualized the expression patterns of the STKs using live
cell confocal microscopy, allowing us to make a subjective
FIG. 3. Entry clone diagnostics and
sequencing. a, example of a diagnostic
BanII restriction digest profile of selected
serine-threonine kinases. The common
3-kb band in lanes 1–16 represents the
entry vector backbone. The table lists
the expected digest pattern in addition
to further gene details. b, schematic
demonstrating primer design for ORF
sequencing. Gene-specific primers are
generated along both strands of each
target gene, spaced 500 bases apart.
Two entry vector-specific flanking prim-
ers (SeqLA, TCGCGTTAACGCTAGCA-
TGGATCTC; SeqLB, GTAACATCAGA-
GATTTTGAGACACGGG) provide end
sequence.
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determination of the subcellular localization of the STKs. Im-
portantly, screening for localization by this method allowed us
to determine whether the N- and C-terminally tagged versions
co-localized and if there were differences in localization pat-
terns across different cells.
Here we highlight three examples in RAW264.7 cells to
emphasize the relevance and utility of a large scale cloning
and subcellular localization screen. The p21-activated kinases
(Paks) bind to and may be stimulated by activated forms of
the small GTPases Cdc42 and Rac. The Pak5 and Pak6
isoforms belong to the recently recognized Group II Paks (24).
In the RAW264.7 line, we observed Pak5 localization as a
punctate pattern along the cellular membrane (Fig. 6a), which
differs from previously published reports showing association
with mitochondria (25). The same pattern of Pak5 localization
is observed with both N and C-terminal CFP/YFP fusions. We
noted differential Pak6 localization depending on the terminus
at which CFP/YFP is expressed. With N-terminal tagging, we
observed the disperse cytoplasmic localization of Pak6 de-
scribed previously in CV-1 cells (26). However, with C-termi-
nal CFP or YFP, we detected a more distinct localization of
Pak6 to the plasma membrane (Fig. 6b). This finding may
provide insight into the cellular mechanisms that regulate
Pak6 localization.
Cyclin-dependent kinases (Cdks) have been shown to be
key players in the control of cell cycle progression. Their
activity is regulated by interaction with specific subunits
known as cyclins, phosphorylation by other protein kinases,
and dephosphorylation by phosphatases (27). Based on se-
quence homology, Pctaire2 is a Cdk-related gene and is likely
FIG. 4. AfCS plasmid database vector types and barcodes. The ORF from the entry vector recombines with the parent vector backbone
to generate an expression construct. In the AfCS plasmid database, entry vectors and expression vectors, which both contain a cloned ORF,
are classified as constructs, whereas parent vectors remain in a separate category. The tables to the right describe the components of the AfCS
barcode system for each vector type.
FIG. 5. Schematics of ORF transfer by recombinational cloning to generate expression clones for subcellular localization studies.
ORF-T form contains the stop codon, whereas ORF-N form lacks the stop codon. ORF sequence is transferred to expression vectors via LR
recombination. The T form is CFP- or YFP-tagged at the N terminus; the N form is CFP- or YFP-tagged at the C terminus.
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FIG. 6. Subcellular localization of murine kinases in RAW264.7 cells. Shown are live cell confocal images of RAW 264.7 cells expressing
C/YFP-tagged Pak5 (a), Pak6 (b), and Pctaire2 (c). Brightfield (BF), CFP, YFP, and CFP/YFP merged images are shown. Pak5 localizes to
punctate structures near the plasma membrane, Pak6 shows differential tag-dependent localization, and Pctaire2 localizes to the centrosome.
The AfCS Plasmid and Imaging Databases
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to play a role in cell cycle progression. Here we show the first
example of punctate localization of Pctaire2 potentially at the
centrosome (Fig. 6c). In most cells, N- or C-terminal tagging
does not seem to disrupt this localization (see Fig. 6c, upper
panels). However, in some cells, we find that C-terminal tag-
ging does disrupt Pctaire2 localization from the centrosome in
the same cell in which an N-terminally tagged version still
localizes to this region (see Fig. 6c, lower panels). Overall
these data demonstrate that large scale subcellular localiza-
tion studies cannot only confirm previous findings but also
reveal alternative or novel data that provide the basis for new
hypotheses about protein function.
DISCUSSION
The cloning of large numbers of cDNA ORFs is a challeng-
ing task that requires capable software systems and robust
technical methodology as well as efficient, facile, and acces-
sible data curation. We describe the generation of a publicly
available cDNA collection by the AfCS consortium with em-
phasis on the STK gene family. Although reference is made to
an initial set of 217 STK target genes (of which 124 were
successfully cloned and databased), this group was limited by
the lack of a publicly available mouse genome sequence at
the outset of the project. Our scope was expanded with the
completion of the mouse genome (28), and the entire set of
murine kinase genes (the mouse “kinome”) is now proposed
to number 540 genes (19) of which the AfCS has cloned and
distributed 260. Fig. 7 shows a phylogenetic tree derived
from the human kinome (20) that highlights the murine protein
kinase orthologs cloned and distributed as part of the AfCS
effort. In addition to wild type kinase cDNAs, we also created
mutant cDNAs encoding kinases where the essential lysine
residue in the kinase domain was mutated to arginine. This
“Lys to Arg” mutation creates a potential dominant negative
for almost 200 kinases. These mutants have also been dis-
tributed to the ATCC.
We managed the curation of our cloned cDNAs by creating
the AfCS plasmid database (www.signaling-gateway.org/data/
plasmid/). This database is a dynamic and flexible resource
that represents a long term and ongoing repository of not only
STK-containing but all publicly available AfCS vectors. Users
can also perform blast searches of the AfCS collection at this
site.
In addition to the kinase cDNA set, many additional genes
with key roles in cell signaling were cloned as part of the AfCS
effort. Other gene families strongly represented in this group
include heterotrimeric G proteins, G protein-coupled recep-
tors, small G proteins, guanine nucleotide exchange factors,
and phospholipases. A comprehensive set of pleckstrin ho-
mology domains were also cloned and distributed. The total
number of unique full-length ORFs cloned and fully se-
quenced in Gateway entry vectors, and currently available at
the ATCC, is 449 (Supplemental Table 4). The majority of
these are available in two forms (a termination codon) to
permit expression as either N- or C-terminal fusions with
various tags (see Supplemental Table 3 for list of expression
options). Although Supplemental Table 4 shows only one
representative clone for each unique gene, splice variants
were cloned for several genes. For example, a keyword
search with the Mek7 gene name at www.signaling-gateway.
org/data/plasmid/ finds 44 constructs containing six different
variants of Mek7.
A primary application for these cDNAs in the AfCS program
was the creation of a subcellular localization database gen-
erated through expression of cDNAs as CFP and YFP fusion
proteins in the RAW264.7 macrophage cell line and the
WEHI231 B cell line (www.signaling-gateway.org/data/Da-
ta.html) (29). Thus, the majority of “ready-to-use” expression
constructs available through the ATCC are CFP or YFP fusion
constructs for mammalian expression. An additional resource
that was created as part of the imaging project was a com-
prehensive set of localization markers for various organelles
(34). These have been made available by the ATCC in a
96-well plate to provide the entire 64 plasmid set in an ac-
cessible format (ATCC ID MBA-91 and Supplemental Table 5).
We describe localization data in RAW264.7 macrophages
for the kinases Pak5, Pak6, and Pctaire2. Pak5 and Pak6 are
highly homologous and belong to the recently recognized
Group II Paks (Paks 4, 5, and 6) that retain 40–50% identity to
the kinase domains of the Group I Paks (Paks 1, 2, and 3) (24,
30). We observed a distinct punctate pattern for Pak5 local-
ization along the cellular membrane that does not seem to be
disrupted by N- or C-terminal tagging (Fig. 6a). Because pre-
vious studies observed Pak5 localization in mitochondria of
Chinese hamster ovary cells, it is possible that Pak5 localiza-
tion is dynamic and varies between cell types. Expression of the
N-terminal fusion of Pak6 exhibits the previously observed dis-
perse cytoplasmic localization (26). However, the C-terminal
fusion reveals a more distinct plasma membrane location (Fig.
6b). Pak6 contains a PAK box domain (PBD), characteristic of
the Pak kinases (31). It is possible that C-terminal tagging dis-
rupts the function of the PBD domain and, by extension, the
Fig. 7. Protein kinase phylogenetic tree. Relationships between members of the protein kinase superfamily (kinome dendrogram reprinted
with permission from Cell Signaling Technology, Inc. and Manning et al. (20)) are shown. Group names are: AGC, containing cAMP-dependent
protein kinase (PKA), cGMP-dependent protein kinase (PKG), and protein kinase C (PKC); CAMK, calcium/calmodulin-dependent protein
kinase; CK1, casein kinase 1; CMGC, containing CDK, mitogen-activated protein kinase (MAPK), glycogen synthase kinase 3 (GSK3), and
CDC-like kinase (CLK) families; STE, homologs of the yeast Sterile kinases; TK, tyrosine kinase; TKL, tyrosine kinase-like. Insets highlight
several atypical and mouse-specific kinases in the AfCS collection. The murine orthologs of all kinases highlighted red are represented in the
AfCS plasmid database and are available through the ATCC (see Supplemental Table 4 for clone IDs).
The AfCS Plasmid and Imaging Databases
Molecular & Cellular Proteomics 6.3 421
 at California Institute of Technology on July 30, 2007 
w
w
w
.m
cponline.org
D
ow
nloaded from
 
cellular compartmentalization of Pak6. On the other hand, the
specific membrane localization of the C-terminal CFP/YFP fu-
sion may provide insight into how engagement of the PBD
domain could dynamically regulate Pak6 localization.
Based on sequence homology, Pctaire2 is a Cdk-related
gene and likely plays a role in cell cycle progression (27, 32).
Previous localization studies of Pctaire1 show abundant cy-
toplasmic localization (32). Here we show the first example of
distinct localization of Pctaire2 that, in most cells, appears to
be at the centrosome with both N- or C-terminal tagging (Fig.
6c). It is noteworthy that we find a small proportion of cells
where C-terminally tagged Pctaire2 is delocalized from the
centrosome while the N-terminally tagged form remains local-
ized (Fig. 6c, lower panels). This observation may provide
insight to a dynamic role for the Pctaire2 C terminus during
certain stages of the cell cycle. These data demonstrate how
expression constructs from the AfCS collection can provide
informative data on the localization of signaling genes that
may lead to important insights into protein function. In addi-
tion, the CFP/YFP fluorescent tags were chosen for their
compatibility in fluorescence resonance energy transfer stud-
ies, which can provide data on the real time interaction kinet-
ics of dynamically associated proteins (e.g. heterotrimeric G
protein subunits). Indeed all of the constructs available in the
AfCS plasmid database can provide the foundation for further
analyses working toward a better understanding of complex
cellular signaling networks.
In general, the cDNA cloning protocol we describe proved
to be robust for the isolation of a large number of murine
signaling genes. As a standard source material, a mixture of
brain and testes cDNA appears to provide the most compre-
hensive coverage of genes involved in the major cell signaling
pathways. Analysis of the genes that we failed to amplify
shows a bias toward large cDNAs. However, we were still able
to clone 17 ORFs of 3 kb using the ProofStart polymerase.
We found that this enzyme provided the best balance of
robustness of amplification versus fidelity. Furthermore we
could readily identify randomly generated PCR mutations by
running separate PCRs for cDNAs with and without the ter-
mination codon (Fig. 1). In most cases, we expect that the
differences we observed between our cloned sequences and
the GenBank reference were caused by either splice variation
between the originally sequenced ORF and ours, genuine
polymorphisms, or sequence inaccuracies from more dated
sequencing technologies. For example, we cloned the hetero-
trimeric G protein Gi2 from the sequence in GI: 6680036 and
observed five differences in the nucleotide sequence. Com-
parison with the current RefSeq record for Gi2 (GI:
41054805) shows a perfect match between the AfCS and
RefSeq sequences at these five locations. Interestingly there
are three presumed polymorphisms between the AfCS and
RefSeq sequences at other locations, but these three nucle-
otide differences are “silent” with respect to amino acid se-
quence (data not shown).
Our adoption of the Gateway cloning technology at the
outset of this effort greatly facilitated the cloning process (4).
The resource described here is specific to cDNA cloning, but
we have also used Gateway extensively in the cloning of short
hairpin RNAs for RNA interference, initially as RNA polymer-
ase III promoter-driven stem loops (www.signaling-gateway.
org/data/plasmid/RNAi_vector_guide.pdf) and more recently
as conditionally expressed microRNA-like-short hairpin RNAs
(33). The recombination reactions used for both cloning PCR
products and subcloning to expression platforms for func-
tional analysis have proven to be highly robust and scalable to
96-well plate formats. Moreover our development of custom
software scripts allowed us to automate the generation of
plasmid database records, an approach that was particularly
useful for batch calculations of diagnostic restriction maps for
validating constructs after recombination.
In summary, the constructs generated and distributed to
the ATCC by the AfCS consortium represent a valuable ex-
perimental resource for the cell signaling research commu-
nity. We present only a small subset of the localization data
available at the AfCS image database (www.signaling-gate-
way.org/data/Data.html), so this data resource can provide
significantly more insight and experimental leads than what
we are able to highlight in this report. Moreover these local-
ization screens are only one of many applications for this
Gateway-compatible clone set. The AfCS ORFs described
here are also available from the ATCC in Gateway entry vec-
tors. Thus, subcloning to other Gateway-compatible expres-
sion platforms (such as those detailed in Supplemental Table
3 and others available commercially) would allow many addi-
tional proteomics applications to further investigate the mo-
lecular function of the signaling genes in the AfCS collection.
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